Business
PharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts, Oils and Veterinary Products to Laboratorios Adler
PharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n\n\n\nPharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts, Oils and Veterinary Products to Laboratorios Adler\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO and MONTEVIDEO, Uruguay, Aug. 13, 2019\n\n\n\nCBD extracts and oils to be used in Adler's portfolio of veterinary products for pain and cancer treatment in large and domestic animals Agreement also includes supply of Creso Pharma's anibidiol® products This is PharmaCielo's first foray into the growing veterinary CBD market Agreement covers sales and distribution in Uruguay, Paraguay, Bolivia and Southern Brazil TORONTO and MONTEVIDEO, Uruguay, Aug. 13, 2019 /CNW/ - PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV:PCLO, OTC:PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced it has signed a sales agreement with Uruguay-based Laboratorios Adler (\"Adler\"). According to the agreement, PharmaCielo will provide Adler with bulk CBD extracts, bulk and bottled CBD oils and veterinary products that will be sold by Adler in Uruguay, Paraguay, Bolivia and Southern Brazil.\n\n \n \n\n \nThe four-and-a-half-year agreement with option for renewal signals PharmaCielo's foray into the high-growth veterinary CBD treatment and wellness market. This is also the first collaboration between PharmaCielo and Creso Pharma that includes sub-contracting to Creso the responsibility for manufacture and supply of Creso's veterinary feed products, anibidiol® 2.5 and anibidiol® 8, with export approval received from the Swiss Cantonal regulator.\n\"This exciting entry into the animal health marketplace through the agreement with Adler is an example of PharmaCielo executing on its strategic objectives to supply both bulk oil and proprietary products to customers using established large chain distributors,\" said David Attard, CEO with PharmaCielo Ltd. \"Including Creso Pharma's animal health products also demonstrates both t...